Among patients with uncontrolled hypertension, the investigational drug lorundrostat brought a significant reduction in blood pressure at 12 weeks compared with placebo, according to a study presented ...

ShORe Phase 3 topline results accelerated; trial did not meet primary endpoint of mean change in BCVA from baseline to week 52Opthea and DFA ...

The growing interest in Mounjaro shows an increasing awareness of metabolic health, which is a positive trend. However, ...

MG Cyberster pre-bookings open ahead of imminent launch, to be sold alongside MG M9. JSW MG Motor India has commenced ...

Novo Nordisk (NVO) presented results from STRIDE, its phase 3b trial investigating the effects of once-weekly Ozempic injection 1 mg in adults ...

Emma Meczywor had an eight-goal, five-assist afternoon on the turf at Berkshire Community College, bringing her to 371 career points. That is in range of the Hurricanes' scoring record set by Alie ...

Just as effective as the high dose, low-dose apixaban prevents long-term recurrent venous thromboembolism in patients with ...

The investigational aldosterone synthase inhibitor lorundrostat effectively lowered 24-hour BP for adults with well-treated, uncontrolled and “true” treatment-resistant hypertension, according to data ...

CHICAGO — Lepodisiran, a small interfering RNA agent, lowered lipoprotein(a) levels at 180 days, with a reduction of more ...

Daily apple consumption delivers 7 proven health benefits including better digestion, weight control, and heart health, ...

While it can affect your body differently when you have diabetes, sugar doesn’t have to be completely off the table.

Survivorship Care is highlighted, providing emotional, physical, and practical care for patients, along with other positive data to be aware of.